Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Johns Hopkins scientists have by chance discovered that a widely used means of illuminating cancer cells could undermine studies of the potential value of experimental anti-cancer drugs because the natural “pump” that cells use to clear out the chemical light source alters their chemistry.
One year after completing the first large-scale report sequencing breast and colon cancer genes, Johns Hopkins Kimmel Cancer Center scientists have studied the vast majority of protein-coding genes which now suggest a landscape dominated by genes that each are mutated in relatively few cancers.
The Johns Hopkins Kimmel Cancer Center has received a $50,000 grant from the National Breast Cancer Foundation for providing free mammograms to underserved women in Baltimore. The grant is provided through Colgate-Palmolive and will be presented to the Kimmel Cancer Center on Wednesday at 12 noon, as part of their “String of Life” campaign to raise awareness of the importance of early detection and getting a yearly mammogram.
Martin D. Abeloff, M.D., the chief oncologist and director of the Johns Hopkins Kimmel Cancer Center for the past 15 years, died Sept. 14 of leukemia. Abeloff, 65, was an international authority on the treatment of breast cancer.
A father-son research team working from separate laboratory benches across the country has discovered a new use for lasers — zapping viruses out of blood. The technique, which holds promise for disinfecting blood for transfusions, uses a low-power laser beam with a pulse lasting just fractions of a second.
A drug that shuts down a critical cell-signaling pathway in the most common and aggressive type of adult brain cancer successfully kills cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy, a Johns Hopkins study shows.
Researchers at the Johns Hopkins Kimmel Cancer Center have found a genetic signature for aggressive melanomas.
SHORT CHROMOSOMES PUT CANCER CELLS IN FORCED REST A Johns Hopkins team has stopped in its tracks a form of blood cancer in mice by engineering and inactivating an enzyme, telomerase, thereby shortening the ends of chromosomes, called telomeres.
People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease.
Opening Doors: Contemporary African American Academic Surgeons is a celebration of the contributions of African-American academic surgeons. It tells the stories of four pioneering African-American surgeons and educators, like those at the Johns Hopkins School of Medicine, who exemplify excellence in their fields and believe in continuing the journey of excellence through the education and mentoring of young African Americans pursuing medical careers.
Drugs play on output of genes linked to “cell-signaling” proteins Building on newly discovered genetic threads in the rich tapestry of biochemical signals that cause cancer, a Johns Hopkins Kimmel Cancer Center team has dramatically killed brain cancer cells by blocking those signals with a statin and an experimental antitumor drug.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins has been named the primary recipient of the 2006 grants from Curing Kids’ Cancer, the charity that raises money for leading edge pediatric cancer research through kids’ sports teams and school children. A $100,000 grant was given to Johns Hopkins for research into new targeted therapies for acute lymphoblastic leukemia, the most common childhood cancer.